|
DENND4A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.599800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.248380E-01 |
| Normal-vs-Stage2 |
3.994000E-01 |
| Normal-vs-Stage3 |
4.796800E-04 |
| Normal-vs-Stage4 |
4.34080000000225E-06 |
| Stage1-vs-Stage2 |
7.839200E-01 |
| Stage1-vs-Stage3 |
1.540140E-02 |
| Stage1-vs-Stage4 |
1.765330E-04 |
| Stage2-vs-Stage3 |
9.557500E-02 |
| Stage2-vs-Stage4 |
1.267730E-02 |
| Stage3-vs-Stage4 |
1.715980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.005900E-02 |
| Normal-vs-AfricanAmerican |
1.194870E-04 |
| Normal-vs-Asian |
4.015400E-01 |
| Caucasian-vs-AfricanAmerican |
1.418330E-02 |
| Caucasian-vs-Asian |
9.473800E-01 |
| AfricanAmerican-vs-Asian |
3.113400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.036100E-03 |
| Normal-vs-Female |
4.258400E-02 |
| Male-vs-Female |
4.179800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.294400E-02 |
| Normal-vs-Age(41-60Yrs) |
7.538500E-02 |
| Normal-vs-Age(61-80Yrs) |
3.575400E-04 |
| Normal-vs-Age(81-100Yrs) |
9.503700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.881000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.586200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.458600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.723800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.620800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.994200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.933400E-01 |
| Normal-vs-Grade 2 |
1.672820E-01 |
| Normal-vs-Grade 3 |
1.100750E-03 |
| Normal-vs-Grade 4 |
4.63729999999885E-06 |
| Grade 1-vs-Grade 2 |
4.887400E-01 |
| Grade 1-vs-Grade 3 |
7.848400E-02 |
| Grade 1-vs-Grade 4 |
7.178900E-03 |
| Grade 2-vs-Grade 3 |
1.612290E-02 |
| Grade 2-vs-Grade 4 |
1.384350E-04 |
| Grade 3-vs-Grade 4 |
3.713900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.484600E-01 |
| Normal-vs-ccB subtype |
1.219700E-02 |
| ccA subtype-vs-ccB subtype |
1.417940E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.456500E-02 |
| Normal-vs-N1 |
8.574300E-02 |
| N0-vs-N1 |
5.685400E-01 |
|
|
